Wealth Enhancement Advisory Services
BNTX icon

Wealth Enhancement Advisory Services’s BioNTech BNTX Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,906
Closed -$202K – 3674
2025
Q3 		$202K Buy
+1,906
New +$204K ﹤0.01% 3133
2025
Q1 		– Sell
-2,089
Closed -$238K – 3004
2024
Q4 		$238K Buy
+2,089
New +$238K ﹤0.01% 2570

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wealth Enhancement Advisory Services's BNTX Position: Q4 2025 in Review

Wealth Enhancement Advisory Services sold out of BioNTech (BNTX) in Q4 2025, closing a stake of 1,906 shares — an estimated $202K sold.

Wealth Enhancement Advisory Services first reported a position in BNTX in Q4 2024 and held it in 2 quarters. The position peaked at $238K in Q4 2024. 284 funds tracked by Wall St. Rank hold BNTX as of Q4 2025.

  • Wealth Enhancement Advisory Services reported no remaining BioNTech position as of Q4 2025 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 1,906 BioNTech shares in Q4 2025, an estimated $202K.
  • Wealth Enhancement Advisory Services first reported a position in BioNTech in Q4 2024 and held it in 2 quarters.
  • Wealth Enhancement Advisory Services's BioNTech position peaked at $238K in Q4 2024.
  • 284 funds tracked by Wall St. Rank held BioNTech as of Q4 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2025, filed 8 Jan 2026.